U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H29N3O4
Molecular Weight 435.5155
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MILVETEROL

SMILES

O[C@@H](CNCCC1=CC=C(NC[C@H](O)C2=CC=CC=C2)C=C1)C3=CC=C(O)C(NC=O)=C3

InChI

InChIKey=BMKINZUHKYLSKI-DQEYMECFSA-N
InChI=1S/C25H29N3O4/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29)/t24-,25-/m0/s1

HIDE SMILES / InChI

Molecular Formula C25H29N3O4
Molecular Weight 435.5155
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Milveterol (also known as GSK159797) was developed as a longer-acting beta2 adrenoceptor agonist for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Milveterol completed phase II clinical trials for asthmatic subjects. However further development of the drug was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Novel bronchodilators in asthma.
2010 Jan
A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD.
2012 Jan 15
Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends.
2015 May 28
Patents

Sample Use Guides

GSK159797 (10, 15, and 20mcg) following dosing for 14 days
Route of Administration: Respiratory
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:55:00 UTC 2023
Edited
by admin
on Sat Dec 16 16:55:00 UTC 2023
Record UNII
LGY1VQ9622
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MILVETEROL
INN  
INN  
Official Name English
milveterol [INN]
Common Name English
GSK-159797
Code English
FORMAMIDE, N-(2-HYDROXY-5-((1R)-1-HYDROXY-2-((2-(4-(((2R)-2-HYDROXY-2-PHENYLETHYL)AMINO)PHENYL)ETHYL)AMINO)ETHYL)PHENYL)-
Systematic Name English
GSK159797
Code English
N-(2-HYDROXY-5-((1R)-1-HYDROXY-2-((2-(4-(((2R)-2-HYDROXY-2-PHENYLETHYL)AMINO)PHENYL)ETHYL)AMINO)ETHYL)PHENYL)FORMAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C48149
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
Code System Code Type Description
FDA UNII
LGY1VQ9622
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
PUBCHEM
9892481
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
DRUG BANK
DB05043
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
INN
8870
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
SMS_ID
300000034306
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
NCI_THESAURUS
C77935
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
ChEMBL
CHEMBL1940832
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
CAS
652990-07-3
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
EPA CompTox
DTXSID30215640
Created by admin on Sat Dec 16 16:55:00 UTC 2023 , Edited by admin on Sat Dec 16 16:55:00 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY